DFMO as Maintenance Therapy for Molecular High/Very High Risk and Relapsed Medulloblastoma
Clinical trial NCT04696029 · RECRUITING
Trial details
- NCT number
- NCT04696029
- Sponsor
- Giselle Sholler
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-03-29
- Primary completion
- 2028-03-01
- Enrollment
- 118
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.